当前位置: X-MOL 学术Immun. Inflamm. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID-19 during a SARS-coronavirus-2 outbreak in a senior citizen home in Germany
Immunity, Inflammation and Disease ( IF 2.493 ) Pub Date : 2021-09-16 , DOI: 10.1002/iid3.532
Rolf Schwarzer 1 , Sabine D Freys 2 , Nick Neuwinger 1 , Nina Beikert 1 , Bettina Eberspächer 1 , Anke Edelmann 1 , Marta Zuchowski 1 , Inga Slothouwer 1 , Angela Stein 1 , Kathrin Theil 1 , Peter Menzel 1 , Jörg Hofmann 1
Affiliation  

Background: A total of 62/66 (93.9%) residents in a senior citizen home in Bremen, Germany, received the first dose of the Biontech/Pfizer vaccine BNT162b2 on December 27th 2020. After routine severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen tests showed positive results on January 5th, all residents and staff were tested by RT-PCR.

中文翻译:

在德国一所老年人之家爆发 SARS-coronavirus-2 期间,单剂 Biontech/Pfizer BNT162b2 疫苗保护老年居民免受严重的 COVID-19

背景:2020 年 12 月 27 日,德国不来梅一所养老院共有 62/66(93.9%)居民接种了第一剂 Biontech/Pfizer 疫苗 BNT162b2。在常规严重急性呼吸系统综合症冠状病毒 2(SARS- 1月5日,CoV-2)抗原检测呈阳性,所有居民和工作人员均接受了RT-PCR检测。
更新日期:2021-11-13
down
wechat
bug